157 related articles for article (PubMed ID: 29582819)
1. Vitreous rebleed following sutureless vitrectomy: Incidence and risk factors.
Mahalingam P; Topiwalla TT; Ganesan G
Indian J Ophthalmol; 2018 Apr; 66(4):558-561. PubMed ID: 29582819
[TBL] [Abstract][Full Text] [Related]
2. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy.
Ding Y; Yao B; Hang H; Ye H
BMC Ophthalmol; 2020 Jul; 20(1):292. PubMed ID: 32677996
[TBL] [Abstract][Full Text] [Related]
3. Ocular findings at initial pan retinal photocoagulation for proliferative diabetic retinopathy predict the need for future pars plana vitrectomy.
Parikh R; Shah RJ; VanHouten JP; Cherney EF
Retina; 2014 Oct; 34(10):1997-2002. PubMed ID: 24936944
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
[TBL] [Abstract][Full Text] [Related]
6. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
Retina; 2009; 29(7):926-31. PubMed ID: 19584650
[TBL] [Abstract][Full Text] [Related]
7. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Immediate and Delayed Vitrectomy for the Management of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy.
Fassbender JM; Ozkok A; Canter H; Schaal S
Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):35-41. PubMed ID: 26731207
[TBL] [Abstract][Full Text] [Related]
9. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
10. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
Luttrull JK; Musch DC; Spink CA
Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
[TBL] [Abstract][Full Text] [Related]
11. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
12. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Lee BJ; Yu HG
Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
[TBL] [Abstract][Full Text] [Related]
13. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
[TBL] [Abstract][Full Text] [Related]
14. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
[TBL] [Abstract][Full Text] [Related]
15. Pars plana vitrectomy: comparison of three techniques for the treatment of diabetic vitreous hemorrhage.
Bahar I; Axer-Siegel R; Weinberger D
Ophthalmic Surg Lasers Imaging; 2006; 37(5):364-9. PubMed ID: 17017195
[TBL] [Abstract][Full Text] [Related]
16. Use of iOCT in Vitreoretinal Surgery for Dense Vitreous Hemorrhage in a Chinese Population.
Tao J; Wu H; Chen Y; Mao J; Cheng D; Lin J; Shen L
Curr Eye Res; 2019 Feb; 44(2):219-224. PubMed ID: 30299988
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group.
Flynn HW; Chew EY; Simons BD; Barton FB; Remaley NA; Ferris FL
Ophthalmology; 1992 Sep; 99(9):1351-7. PubMed ID: 1407968
[TBL] [Abstract][Full Text] [Related]
18. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
Lee DY; Jeong HS; Sohn HJ; Nam DH
Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
[TBL] [Abstract][Full Text] [Related]
19. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
20. [Vitreous hemorrhages in proliferative diabetic retinopathy treated with pars plana vitrectomy--own material].
Kanclerz P; Pyrzanowska-Sumita J; Murawska J; Raczyńska D; Gebka A
Klin Oczna; 2013; 115(4):291-5. PubMed ID: 24908919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
